S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
S&P 500   4,567.00
DOW   34,483.72
QQQ   393.82
NASDAQ:OYST

Oyster Point Pharma Earnings Date, Estimates, & History

$10.43
+0.12 (+1.16%)
(As of 11/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.14
$10.60
50-Day Range
$10.17
$14.12
52-Week Range
$9.86
$25.89
Volume
197,540 shs
Average Volume
161,552 shs
Market Capitalization
$272.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.2

Earnings Summary

Upcoming
Earnings Date
Feb. 17
Estimated

Actual EPS
(Nov. 4)
-$0.68
Beat By $0.48

Consensus EPS
(Nov. 4)
-$1.16

Last Year's Q4 EPS
(11/5/2020)
-$0.63

Skip Charts & View Estimated and Actual Earnings Data

Oyster Point Pharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Oyster Point Pharma Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Oyster Point Pharma (NASDAQ:OYST) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($1.15)($0.85)($1.00)
Q2 20212($1.35)($1.05)($1.20)
Q3 20212($1.25)($0.80)($1.03)
Q4 20211($1.49)($1.49)($1.49)
FY 20217($5.24)($4.19)($4.72)
Q1 20221($1.18)($1.18)($1.18)
Q2 20221($1.17)($1.17)($1.17)
Q3 20221($1.19)($1.19)($1.19)
Q4 20221($1.19)($1.19)($1.19)
FY 20224($4.73)($4.73)($4.73)

OYST Earnings Information

Oyster Point Pharma last announced its earnings data on November 4th, 2021. The reported ($0.68) earnings per share for the quarter, beating the consensus estimate of ($1.16) by $0.48. Oyster Point Pharma has generated ($3.12) earnings per share over the last year (($3.12) diluted earnings per share). Earnings for Oyster Point Pharma are expected to decrease in the coming year, from ($3.88) to ($4.88) per share. Oyster Point Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 17th, 2022 based off prior year's report dates.

Oyster Point Pharma (NASDAQ:OYST) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
2/17/2022
(Estimated)
        
11/4/20219/30/2021($1.16)($0.68)+$0.48($0.68)    
8/5/20216/30/2021($0.85)($0.85)($0.85)  
5/6/20213/31/2021($0.91)($0.73)+$0.18($0.73)  
2/18/202112/31/2020($0.79)($0.86)($0.07)($0.86)  
11/5/20209/30/2020($0.74)($0.63)+$0.11($0.63)  
8/5/20206/30/2020($0.81)($0.66)+$0.15($0.66)  
5/11/20203/31/2020($1.06)($0.77)+$0.29($0.77)  
2/27/202012/31/2019($0.58)($1.41)($0.83)($1.41)  
12/3/2019Q3 2019($0.51)($8.10)($7.59)($8.10)
(Earnings results data provided by Zacks Investment Research)












Oyster Point Pharma (NASDAQ:OYST) Earnings Frequently Asked Questions

When is Oyster Point Pharma's earnings date?

Oyster Point Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 17th, 2022 based off last year's report dates. Learn more on OYST's earnings history

Did Oyster Point Pharma beat their earnings estimates last quarter?

In the previous quarter, Oyster Point Pharma (NASDAQ:OYST) reported ($0.68) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.16) by $0.48. Learn more on OYST's earnings details

How can I listen to Oyster Point Pharma's earnings conference call?

The conference call for Oyster Point Pharma's latest earnings report can be listened to online. Listen to Conference Call

How can I read Oyster Point Pharma's conference call transcript?

The conference call transcript for Oyster Point Pharma's latest earnings report can be read online. Read Transcript

How much profit does Oyster Point Pharma generate each year?

Oyster Point Pharma (NASDAQ:OYST) has a recorded net income of -$70.52 million. OYST has generated -$3.12 earnings per share over the last four quarters.

What is Oyster Point Pharma's EPS forecast for next year?

Oyster Point Pharma's earnings are expected to decrease from ($3.88) per share to ($4.88) per share in the next year.

This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.